-
CF Patients Adhere Well to CFTR Therapies But High Costs Could Undermine Use, Study Says
A study of CF patients using Vertex therapies via a U.S. specialty pharmacy found 80% complying with treatment as prescribed, but copays and costs rising. Read more about it here.
What are your thoughts about this study and its findings?
Sorry, there were no replies found.
Log in to reply.